Welcome to the UPF Digital Repository
Browsing by Author "Balp, Maria Magdalena"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Balp, Maria Magdalena"
Now showing items 1-9 of 9
-
Stull, Donald; McBride, Doreen; Tian, H.; Giménez Arnau, Anna Maria; Maurer, Marcus; Marsland, Alexander; Balp, Maria Magdalena; Khalil, Sam; Grattan, Clive (Wiley, 2017)BACKGROUND: Measurement of disease activity guides treatment of chronic spontaneous urticaria (CSU). A weekly Urticaria Activity Score - here, the average of twice-daily patient assessment of itch and hives scores summed ...
-
Sussman, Gordon; Giménez Arnau, Anna Maria; Balp, Maria Magdalena (Wiley, 2018)BACKGROUND: ASSURE-CSU revealed differences in physician and patient reporting of angioedema. This post hoc analysis was conducted to evaluate the actual rate of angioedema in the study population and explore differences ...
-
Weller, Karsten; Maurer, Marcus; Grattan, Clive; Nakonechna, Alla; Abuzakouk, Mohamed; Bérard, Frédéric; Sussman, Gordon; Giménez Arnau, Anna Maria; Ortiz de Frutos, Javier; Knulst, André; Canonica, G. Walter; Hollis, Kelly; McBride, Doreen; Balp, Maria Magdalena (BioMed Central, 2015)BACKGROUND: Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the ...
-
Giménez Arnau, Anna Maria; Spector, Sheldon; Antonova, Evgeniya; Trzaskoma, Benjamin; Rosén, Karin; Omachi, Theodore A.; Stull, Donald; Balp, Maria Magdalena; Murphy, Thomas (BioMedCentral, 2016)BACKGROUND: Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. METHODS: We examined the effect of omalizumab on sleep-related outcomes during 3-6 months omalizumab or placebo ...
-
Metz, Martin; Bernstein, Jonathan A.; Giménez Arnau, Anna Maria; Hide, Michihiro; Maurer, Marcus; Sitz, Karl; Soong, Weily; Sussman, Gordon; Hua, Eva; Barve, Avantika; Barbier, Nathalie; Balp, Maria Magdalena; Severin, Thomas (Elsevier, 2022)Background: Disease burden is particularly high in Chronic Spontaneous Urticaria (CSU) patients with angioedema, and patients whose signs and symptoms are inadequately controlled by H1-antihistamines need new treatment ...
-
Giménez Arnau, Anna Maria; Maurer, Marcus; Bernstein, Jonathan A.; Staubach, Petra; Barbier, Nathalie; Hua, Eva; Severin, Thomas; Joubert, Yolandi; Janocha, Reinhold; Balp, Maria Magdalena (Wiley, 2022)Background: Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health-related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often ...
-
Ferrer, Marta; Giménez Arnau, Anna Maria; Saldana, Diego; Janssens, Nico; Balp, Maria Magdalena; Khalil, Sam; Risson, Valéry (Elsevier, 2018)BACKGROUND: Omalizumab is highly effective in controlling chronic spontaneous urticaria (CSU) symptoms; however, patients can experience symptom return on treatment discontinuation. Pivotal clinical trials have identified ...
-
Maurer, Marcus; Giménez Arnau, Anna Maria; Balp, Maria Magdalena (Wiley-Blackwell, 2017)BACKGROUND: Chronic spontaneous urticaria (CSU) can be debilitating, difficult to treat, and frustrating for patients and physicians. Real-world evidence for the burden of CSU is limited. The objective of this study was ...
-
Bernstein, Jonathan A.; Giménez Arnau, Anna Maria; Maurer, Marcus; Staubach, Petra; Barbier, Nathalie; Hua, Eva; Severin, Thomas; Laires, Pedro A.; Balp, Maria Magdalena (MDPI, 2023)This study investigated the association between urticaria activity and health-related quality of life (HRQoL). Patient evaluations from the ligelizumab Phase 2b clinical trial (N = 382) were pooled (NCT02477332). Daily ...
Now showing items 1-9 of 9
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00